Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
about
The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratioManaging anticoagulation for atrial fibrillation: current issues and future strategiesUntreated atrial fibrillation in the United Kingdom: Understanding the barriers and treatment optionsValidation of low-dose aspirin prescription data in The Health Improvement Network: how much misclassification due to over-the-counter use?Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database.Current issues in patient adherence and persistence: focus on anticoagulants for the treatment and prevention of thromboembolism.A review of the safety of anticoagulants in older people using the medicines management pathway: weighing the benefits against the risksComparison of the clinical features and outcomes in two age-groups of elderly patients with atrial fibrillation.A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.Warfarin discontinuation after starting warfarin for atrial fibrillation.Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.A cluster-randomized controlled trial of a computerized antithrombotic risk assessment tool to optimize stroke prevention in general practice: a study protocol.Drug persistence with rivaroxaban therapy in atrial fibrillation patients-results from the Dresden non-interventional oral anticoagulation registryDabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analysesUK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database.Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation.Differences in anticoagulant therapy prescription in patients with paroxysmal versus persistent atrial fibrillation.Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE RegistryLong-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study.Is real world evidence influencing practice? A systematic review of CPRD research in NICE guidances.Adherence to oral anticoagulants in patients with atrial fibrillation-a population-based retrospective cohort study linking health information systems in the Valencia region, Spain: a study protocol.Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional surveyDrug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.Survival analysis using primary care electronic health record data: A systematic review of the literature.Falls and Atrial Fibrillation in Elderly PatientsAn international longitudinal registry of patients with atrial fibrillation at risk of stroke (GARFIELD): the UK protocolUsing an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.The use of anticoagulants in the management of atrial fibrillation among general practices in EnglandOptimizing Stroke Prevention in Patients With Atrial Fibrillation: A Cluster-Randomized Controlled Trial of a Computerized Antithrombotic Risk Assessment Tool in Australian General Practice, 2012-2013.European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial FibrillationCurrent management of atrial fibrillation: an observational study in NHS primary care.Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants.Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III.A brief overview of surgery for atrial fibrillation.A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals.Stroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation.Dabigatran for the prevention of stroke and systemic embolism in atrial fibrillation: A NICE single technology appraisal.Guideline adherence of antithrombotic treatment initiated by general practitioners in patients with nonvalvular atrial fibrillation: a Danish survey.
P2860
Q26776239-477F74D5-0823-4EB4-A1D5-B0E8DC53DBC8Q26991728-A9B34281-7D3E-4A19-BAAE-C5EDFCFC54DDQ28081837-2BA0C454-88D7-456E-BB59-152B7B726EABQ31031802-04624D9A-91A3-479B-97AA-4E90951042F7Q33506410-9811AD38-2689-47B0-AD73-1E2E9F017998Q33755738-B3EDEF1E-9E96-4A3C-B375-48DE943C87ECQ33949244-798973E0-7B5E-4D77-B5AE-34B1F5BE1A69Q34062233-EB4B23E9-09D9-4F7C-BC18-86C88FE1E123Q34146593-2D9B3D3A-2435-4FF8-BB2D-972F086B2DA8Q34317469-17BDA7B6-C66A-419A-BBF9-39E07A27BCDFQ34713428-B74ABF8F-DCDD-4694-B4F6-0C34E0A61AC3Q34769114-6E0AD7BC-04FA-4471-9F1F-E4A3C90F8326Q35089113-396197AA-B844-4A82-820C-353B813273D9Q35239819-004E4B2E-F7E9-4585-B256-0425412868E1Q35485247-0F5FA0E7-982F-45B3-8642-FE3873248C00Q35536185-2A1E7956-05E6-47D6-BDB4-1BCE1E472A71Q35629873-EA98931D-A9C0-40D8-8533-9FF11AB8CCB3Q35841464-E3B5CA6D-6EF7-41CD-822D-7696315D81DBQ35966775-0D8391E6-8085-40B4-A882-666D5D065367Q35966802-B9DCB93E-B5DA-45AB-BDFF-190B4B82AE70Q36012558-C40966D4-02CA-4857-9196-2B0F5AC540C6Q36085309-CBD70C9F-8EC6-4AF8-85DE-B7FA97F625EDQ36179688-B71727B1-4267-4070-8120-D52F74C765DAQ36284273-B1679FD3-FD2A-4143-831E-93A670276992Q36314750-6389C553-4EE1-44C0-B2CB-E498AA5576B6Q36379016-B38AB12B-AD55-4B13-B7F1-1187F2888F94Q36721168-A5BC6066-BC71-4FFF-ABC5-8C7369F7B3D5Q36805599-4DDA6E92-FC20-4B1F-9674-9A84C355C77BQ36951700-00717F46-34FF-4C4D-83C1-4997A0AAB34CQ37030961-E19E2F37-3119-4BB3-875B-81CF14544DAFQ37109120-E0655C8B-5652-4335-8752-E19444DAF814Q37157549-CB0CB186-11E8-48C3-8376-69BD6C2B5C6AQ37342387-5A07803C-4CF1-4182-964B-0477A8E9A7EAQ37437878-75A00590-5899-4386-A0CA-B01C82E81DC5Q37523123-018D8C41-662A-4070-B7A3-07BB2D564D62Q37523156-5D911BA9-F315-4E59-802F-84E9CC40DA66Q37590855-D37C6EB2-83C8-4FFD-84E5-598222F84BC5Q37945342-C8095C6F-AB9E-4421-8734-3D5FF3969123Q38101892-2F41A897-DAD2-45CB-8EE8-B59EDC52055CQ38106663-7E369DFA-E6AE-45C6-A186-E7A84BA71B97
P2860
Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Initiation and persistence of ...... ts receive stroke prophylaxis?
@en
Initiation and persistence of ...... ts receive stroke prophylaxis?
@nl
type
label
Initiation and persistence of ...... ts receive stroke prophylaxis?
@en
Initiation and persistence of ...... ts receive stroke prophylaxis?
@nl
prefLabel
Initiation and persistence of ...... ts receive stroke prophylaxis?
@en
Initiation and persistence of ...... ts receive stroke prophylaxis?
@nl
P2093
P1476
Initiation and persistence of ...... ts receive stroke prophylaxis?
@en
P2093
A M Gallagher
S Rietbrock
P304
P356
10.1111/J.1538-7836.2008.03059.X
P577
2008-06-28T00:00:00Z